Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal products include the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator; Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. The company was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
| Market Capitalization | $91.6688 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | |
| Book Value | -0.006 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.2 |
| EBITDA | -15,944.905 |
| Profit Margin | 0 |
| Operating Margin TTM | -34.9476 |
| Return on Assets TTM | -0.8172 |
| Return on Equity TTM | -2.7456 |
| Revenue TTM | 477.068 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2016-12-31 | 523.29 | 50 | 473.29 | 4,574.633 |
| 2017-12-31 | 433.54 | 0 | 433.54 | 5,394.825 |
| 2018-12-31 | 1,002.45 | 1,002.449 | 5,819.687 | |
| 2019-12-31 | 639.704 | 377.365 | 262.339 | 13,012.878 |
| 2020-12-31 | 702.161 | 1,099.833 | -397.672 | 12,107.092 |
| 2021-12-31 | 696.267 | 2,592.191 | -1,895.924 | 19,148.33 |
| 2022-12-31 | 816.011 | 2,342.795 | -1,526.784 | 16,468.301 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2016-12-31 | 2,089.084 | 2,509.06 | 5,427.6 | 0 | 1,630 | 369.882 |
| 2017-12-31 | 1,769.08 | 2,345.39 | 6,453.45 | 0 | 2,325 | 419.828 |
| 2018-12-31 | 12,436 | 16,057 | 2,588 | 333 | 9,596.61 | 47,295 |
| 2019-12-31 | 5,048.893 | 10,521.529 | 3,488.112 | 127.263 | 0 | 47,459.121 |
| 2020-12-31 | 25,139.812 | 33,569.416 | 4,753.366 | 198.029 | 81,688.227 | |
| 2021-12-31 | 18,516.208 | 26,864.407 | 4,463.693 | 518.655 | 95,005.431 | |
| 2022-12-31 | 5,687.816 | 13,700.861 | 6,190.421 | 867.177 | 2,182.9 | 97,471.424 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2016-12-31 | -4,084.86 | -3,011.807 | -1,454.16 | |||
| 2017-12-31 | -5,143.879 | -4,329.134 | -320.004 | |||
| 2018-12-31 | -5,448.482 | -4,733.848 | -180.732 | 2,267.1253199999996 | ||
| 2019-12-31 | -13,551.276 | -6,627.993 | 3,460.545 | 1,588.348 | 5,048.893 | |
| 2020-12-31 | -12,974.562 | -12,230.689 | 20,090.919 | 5,048.893 | 25,139.812 | |
| 2021-12-31 | -19,732.54 | -17,488.546 | -6,623.604 | 25,139.812 | 18,516.208 | |
| 2022-12-31 | -17,534.184 | -16,821.693 | -12,828.392 | 18,516.208 | 5,687.816 |